<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03439995</url>
  </required_header>
  <id_info>
    <org_study_id>R01HL126176</org_study_id>
    <nct_id>NCT03439995</nct_id>
  </id_info>
  <brief_title>Goal of Open Lung Ventilation in Donors</brief_title>
  <acronym>GOLD</acronym>
  <official_title>Goal of Open Lung Ventilation in Donors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Donor Network West</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary goal of this study is to assess whether ventilation of deceased organ donors with
      an open lung protective ventilatory strategy will improve donor lung utilization rates and
      donor oxygenation compared to a conventional ventilatory strategy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Deceased organ donors are maintained on life support including mechanical ventilation during
      the time between brain death and organ procurement. The optimal mode of mechanical
      ventilation for deceased organ donors has not been definitively established. Since deceased
      organ donors may develop atelectasis leading to impaired oxygenation, an open lung protective
      ventilatory strategy with higher positive end expiratory pressure (PEEP), lower tidal volume
      and recruitment maneuvers has been hypothesized to be beneficial. Favorable outcomes were
      observed in a European clinical trial comparing open lung protective ventilation (OLPV) to a
      conventional ventilatory strategy in terms of donor oxygenation and lung utilization for
      transplantation (Mascia L et al, Journal of the American Medical Association 2010). However,
      donor management procedures in Europe are much shorter in duration compared to the US and it
      is not clear that these findings are generalizable to the US donor management environment.

      The GOLD trial will test the effect of an OLPV strategy compared to conventional ventilation
      (CV) in the US donor management environment. This multi center trial will enroll 400 brain
      dead organ donors randomized into 1 of 2 treatment arms. After randomization, mechanical
      ventilation will be protocolized according to treatment arm with one arm receiving control
      ventilation (CV) utilizing standard Donor Network West (DNW) protocols and the other arm
      receiving the OLPV strategy with higher positive end expiratory pressure (PEEP) and lower
      tidal volume compared to CV. The primary outcomes is donor lung utilization for
      transplantation.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Enrolled donors will be randomly assigned to two different modes of mechanical ventilation for the duration of donor management</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Outcomes in donors and lung transplant recipients will be done by assessors who are blinded to ventilator treatment assignment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Donor lung utilization rate</measure>
    <time_frame>during donor management period (usually 12-48 hours)</time_frame>
    <description>Percent of donor lungs procured and transplanted into recipient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Donor lung utilization in likely donors</measure>
    <time_frame>during donor management period (usually 12-48 hours)</time_frame>
    <description>Percent of donor lungs used from donors with &lt; 50 pack year smoking, age &lt; 65, negative serologies, and no underlying chronic lung disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Donor oxygenation</measure>
    <time_frame>during donor management period (usually 12-48 hours)</time_frame>
    <description>Change in donor arterial oxygen (PaO2) from enrollment to procurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Donor static compliance of the respiratory system</measure>
    <time_frame>during donor management period (usually 12-48 hours)</time_frame>
    <description>Change in compliance of the respiratory system (in ml/cm H2O) from enrollment to procurement. Static compliance (Cstat) is calculated as Cstat = ΔV / Pplat - PEEP where V is the volume delivered by the ventilator, Pplat is the end-inspiratory plateau pressure and PEEP is the level of positive end expiratory pressure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Donor radiographic atelectasis scoring</measure>
    <time_frame>during donor management period (usually 12-48 hours)</time_frame>
    <description>Change in chest radiograph atelectasis score from enrollment to procurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recipient primary graft dysfunction</measure>
    <time_frame>72 hours after transplant</time_frame>
    <description>International Society of Heart and Lung Transplantation grade 2 or 3 primary graft dysfunction in lung transplant recipient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recipient mortality</measure>
    <time_frame>30 days after transplant</time_frame>
    <description>Lung transplant recipient death</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Brain Death</condition>
  <condition>Organ Donation</condition>
  <condition>Organ Transplant Failure or Rejection</condition>
  <arm_group>
    <arm_group_label>Open Lung Protective Ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Volume cycled assist control ventilation with tidal volume 8 cc/kg predicted body weight, PEEP 10 cm water (H2O), recruitment maneuvers every 8 hours and after any ventilator disconnect</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Volume cycled assist control ventilation with tidal volume 10 cc/kg predicted body weight, PEEP 5 cm H2O, recruitment maneuvers after any ventilator disconnect</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Open lung protective ventilation</intervention_name>
    <description>Higher PEEP, lower tidal volume mechanical ventilation</description>
    <arm_group_label>Open Lung Protective Ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional ventilation</intervention_name>
    <description>Lower PEEP, standard tidal volume mechanical ventilation</description>
    <arm_group_label>Conventional Ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Brain death

          -  Authorization for research

          -  ≥13 years of age

        Exclusion Criteria:

          -  Arterial/Inspired oxygen ratio (PaO2/FiO2) ≤ 150 mmHg

          -  PaO2/FiO2 ≥ 400 mmHg

          -  BMI &gt; 40

          -  Hepatitis B surface antigen positive

          -  Hepatitis C positive

          -  Failure to complete donation process

          -  Hemodynamic instability
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lorraine B Ware, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lorraine B Ware, MD</last_name>
    <phone>615 322 3412</phone>
    <email>lorraine.ware@vanderbilt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael A. Matthay, MD</last_name>
    <phone>415 353 1206</phone>
    <email>michael.matthay@ucsf.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, Munari M, Boifava S, Cornara G, Della Corte F, Vivaldi N, Malacarne P, Del Gaudio P, Livigni S, Zavala E, Filippini C, Martin EL, Donadio PP, Mastromauro I, Ranieri VM. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010 Dec 15;304(23):2620-7. doi: 10.1001/jama.2010.1796.</citation>
    <PMID>21156950</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2018</study_first_submitted>
  <study_first_submitted_qc>February 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2018</study_first_posted>
  <last_update_submitted>February 24, 2018</last_update_submitted>
  <last_update_submitted_qc>February 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Lorraine B. Ware</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Death</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

